Invention Application
- Patent Title: ANTAGONISTS OF PROSTAGLANDIN EP3 RECEPTOR
-
Application No.: US14970930Application Date: 2015-12-16
-
Publication No.: US20160176851A1Publication Date: 2016-06-23
- Inventor: Kevin Bahnck , Daniel Canterbury , David James Edmonds , Kentaro Futatsugi , Esther Cheng Yin Lee , Elnaz Menhaji-Klotz , Jana Polivkova , Robert Vernon Stanton
- Applicant: Pfizer Inc.
- Applicant Address: US NY New York
- Assignee: Pfizer Inc.
- Current Assignee: Pfizer Inc.
- Current Assignee Address: US NY New York
- Main IPC: C07D401/14
- IPC: C07D401/14
Abstract:
Provided herein are antagonists of prostaglandin EP3 receptor, processes to make said antagonists, and methods comprising administering said antagonists to a mammal in need thereof.
Public/Granted literature
- US09738626B2 Antagonists of prostaglandin EP3 receptor Public/Granted day:2017-08-22
Information query
